Macchio rises at Coty
This article was originally published in The Rose Sheet
Executive Summary
Ralph Macchio has been named chief scientific officer and also assumes the newly created post of SVP of global research, the firm announces June 28. Macchio, who won this year's HBA Lifetime Achievement in Product Development award, will be responsible for improving Coty's R&D capabilities, tightening business development across product teams and exploring the possibility of partnering with other firms to identify breakthrough technologies. He joined Coty in 1992 and previously served as the general manager of the firm's Morris Plains research facility. In his new role, Macchio "will continue to push Coty forward and ahead of [its] competitors, while setting new standards for the beauty industry," according to Coty CEO Berend Beetz...
You may also be interested in...
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.